<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title>Frontiers in Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Psychiatry</abbrev-journal-title>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpsyt.2024.1486496</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Preventing psychosis in low resources settings - insights, specificities, and recommendations to the study of clinical high risk for psychosis (CHR) in low-and-middle-income countries</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fekih-Romdhane</surname>
<given-names>Feten</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1318650"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loch</surname>
<given-names>Alexandre Andrade</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/119029"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hallit</surname>
<given-names>Souheil</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/391585"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>The Tunisian Center of Early Intervention in Psychosis, Department of psychiatry &#x201c;Ibn Omrane&#x201d;, Razi Hospital</institution>, <addr-line>Manouba</addr-line>, <country>Tunisia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Tunis El Manar University, Faculty of Medicine of Tunis</institution>, <addr-line>Tunis</addr-line>, <country>Tunisia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Laboratorio de Neurociencias (LIM 27), Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo</institution>, <addr-line>Sao Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBION), Conselho Nacional de Desenvolvimento Cientifico e Tecnol&#xf3;gico</institution>, <addr-line>Sao Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>School of Medicine and Medical Sciences, Holy Spirit University of Kaslik</institution>, <addr-line>Jounieh</addr-line>, <country>Lebanon</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Psychology Department, College of Humanities, Effat University</institution>, <addr-line>Jeddah</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Applied Science Research Center, Applied Science Private University</institution>, <addr-line>Amman</addr-line>, <country>Jordan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Wulf R&#xf6;ssler, Charit&#xe9; University Medicine Berlin, Germany</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Feten Fekih-Romdhane, <email xlink:href="mailto:feten.fekih@gmail.com">feten.fekih@gmail.com</email>; Souheil Hallit, <email xlink:href="mailto:souheilhallit@usek.edu.lb">souheilhallit@usek.edu.lb</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>09</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1486496</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>08</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>08</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Fekih-Romdhane, Loch and Hallit</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Fekih-Romdhane, Loch and Hallit</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/50579/preventing-psychosis-in-low-resources-settings---insights-specificities-and-recommendations-to-the-study-of-clinical-high-risk-for-psychosis-chr-in-low-and-middle-income-countries/overview" ext-link-type="uri">Editorial on the Research Topic <article-title>Preventing psychosis in low resources settings - insights, specificities, and recommendations to the study of clinical high risk for psychosis (CHR) in low-and-middle-income countries</article-title>
</related-article>
<kwd-group>
<kwd>clinical high risk for psychosis (CHR)</kwd>
<kwd>low-and-middle-income countries</kwd>
<kwd>prevention</kwd>
<kwd>psychosis</kwd>
<kwd>psychotic disorder</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="15"/>
<page-count count="3"/>
<word-count count="1025"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Public Mental Health</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Despite its low prevalence, schizophrenia represents a significant public health concern because it carries a substantial and increasing burden of disease, particularly in low-and-middle-income-countries (LAMIC) (<xref ref-type="bibr" rid="B1">1</xref>). The onset of schizophrenia typically occurs in adolescence or emerging adulthood, substantially disrupting the development and functioning. Over half of the individuals diagnosed with first episode psychosis (FEP) struggle to reach expected developmental milestones or to return to their premorbid level of functioning, especially those from middle-income nations and non-European countries as compared to patients from high-income countries (HIC) and Europe (<xref ref-type="bibr" rid="B2">2</xref>). Given these heavy negative implications, preventing schizophrenia and other psychotic disorders has been considered as the &#x201c;most urgent moral, social, economic, public health, and scientific imperatives of our time&#x201d; [(<xref ref-type="bibr" rid="B3">3</xref>), p 104]. As such, there have been growing attempts over the past three decades to intervene sooner in patients with FEP by detecting people at Clinical High Risk for Psychosis (CHR), with the main goal of delaying or preventing the onset of a full-threshold disorder and diminishing the harmful effects of longer duration of untreated psychosis (DUP) (<xref ref-type="bibr" rid="B4">4</xref>). However, the mean DUP was meta-analytically estimated to be still high throughout the world, and to be significantly longer in LAMIC (48.4 weeks) relative to HIC (41.2 weeks) (<xref ref-type="bibr" rid="B5">5</xref>). Besides, there is strong evidence to indicate that general population individuals from LAMIC exhibit greater levels of subclinical psychotic symptoms compared to those from HIC (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>), which might be due, in part, to cultural differences.</p>
<p>These observations emphasize the critical need to promote access to early intervention services (EIS), especially in LAMIC. At present, EIS are distributed unequally across the globe, being mostly implemented in HIC (i.e. Western Europe, 51.1%; East Asia, 17.0%; North America, 17.0%) (<xref ref-type="bibr" rid="B8">8</xref>). This geographical distribution mirrors healthcare disparities between LAMIC and HIC (<xref ref-type="bibr" rid="B9">9</xref>), with LAMIC being faced with low availability of mental health services, lack of resources, high public stigma of mental illness, and limited global health policy attention [e.g., (<xref ref-type="bibr" rid="B10">10</xref>)]. In addition, real-world studies on the CHR paradigm in some regions of the world have been particularly scarce so far. For instance, only a very few longitudinal cohort studies could be identified on CHR in the Middle East and North African region [e.g., Tunisia (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>)], or in the African continent [e.g., Kenya (<xref ref-type="bibr" rid="B13">13</xref>)]. Taken together, some LAMIC appear to be deficient or slow in complying with international standards of prevention and early intervention in psychosis and to be confronted with major challenges in developing and implementing EIS, stressing the urgent need to pay more clinical and research attention to this field in these countries (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>In this context, this Research Topic proposes to address insights, specificities, and Recommendations to the Study of CHR in LAMIC, and comprises four papers. In the first paper, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2023.1148862">Loch et&#xa0;al.</ext-link> conducted a systematic review on CHR studies from LAMIC encompassing 109 studies. The vast majority of studies included (n = 101) were from upper middle-income countries, 8 studies were from middle-income countries, whereas no studies from low-income countries could be identified. The most commonly reported limitations in these studies were difficulties in enrolling subjects, following-up and gathering longitudinal data (20.8%), cross-sectional design (27.1%), and small sample size (47.9%). Other limitations described by the corresponding authors of the papers included were shortage of financial resources (66.7%), lack of involvement of participants in research (58.2%), and cultural barriers (41.7%). The majority of participating researchers (75%) believed that research on CHR needs to be carried-out in a different way in LAMIC compared to HIC, because of cultural and structural issues. Although characteristics of the studies involved in the review were similar to those observed in international research on CHR, several challenges have been pointed out, including lack of researchers, lack of research team stability, limited time for research work for the trained clinical assessment staff. Stigma appeared to be a key topic of concern in LAMIC, and might have negatively affected individuals&#x2019; willingness to participate in CHR research. Authors concluded that cultural factors and stigma should be addressed to improve pathways to care for individuals with psychosis in LAMIC. The second paper by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2023.1254993">Nieto et&#xa0;al.</ext-link> investigated the differences in the prevalence of stressful life events in CHR individuals and those non-CHR with familial high risk for psychosis from an upper-middle-income country in Latin America (Mexico), where there exists multiple barriers to early intervention in psychosis. Findings showed that the CHR group reported significantly more stressful events linked to negative academic experiences compared to the non-CHR group. Bullying experiences, lower educational level and starting to live with a partner were associated with an increased risk for CHR. Based on their results, authors suggested that as negative school experiences may be risk factors for psychosis, schools could be appropriate settings for implementing prevention and early intervention strategies in psychosis. The third study is a scoping review by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2023.1114738">Vivaldi Macho et&#xa0;al.</ext-link> on the impact of the institutional model on psychiatric patients in Chile from the 19th to 21st centuries. The specific objectives were to represent, compare, then discuss the mechanisms underscoring how psychiatry affects health systems and social development in the long term. Chile is a South American country that has recently joined the Latin American psychosis early detection programs initiative, and that is encountering many challenges in the EIS implementation process (<xref ref-type="bibr" rid="B15">15</xref>). The review analyzed 10 primary historical resource along with 10 primary studies, and suggested that the state should be responsible for, and a guarantor of psychiatric patients. In particular, the state was recommended to provide humanitarian and professional support to patients by strengthening the primary care system. The fourth study in this Research Topic by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2024.1370085">Chakrabarty et&#xa0;al.</ext-link> explored mental health problems and their cognitive and demographic correlates among COVID-19 survivors from India. The study&#x2019;s findings indicated that COVID-19 patients exhibited significantly greater mental health issues one year after contracting the virus compared to matched healthy controls, including poorer sleep quality, more severe depression/anxiety, and more cognitive impairment.</p>
</body>
<back>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>FF-R: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft. AL: Writing &#x2013; review &amp; editing. SH: Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s2" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s3" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charlson</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Ferrari</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Santomauro</surname> <given-names>DF</given-names>
</name>
<name>
<surname>Diminic</surname> <given-names>S</given-names>
</name>
<name>
<surname>Stockings</surname> <given-names>E</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>JG</given-names>
</name>
<etal/>
</person-group>. <article-title>Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016</article-title>. <source>Schizophr Bull</source>. (<year>2018</year>) <volume>44</volume>:<page-range>1195&#x2013;203</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/schbul/sby058</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ajnakina</surname> <given-names>O</given-names>
</name>
<name>
<surname>Stubbs</surname> <given-names>B</given-names>
</name>
<name>
<surname>Francis</surname> <given-names>E</given-names>
</name>
<name>
<surname>Gaughran</surname> <given-names>F</given-names>
</name>
<name>
<surname>David</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Murray</surname> <given-names>RM</given-names>
</name>
<etal/>
</person-group>. <article-title>Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies</article-title>. <source>Schizophr Res</source>. (<year>2021</year>) <volume>231</volume>:<page-range>122&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.schres.2021.03.013</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Post</surname> <given-names>SG</given-names>
</name>
</person-group>. <article-title>Preventing schizophrenia and Alzheimer disease: comparative ethics</article-title>. <source>Schizophr Res</source>. (<year>2001</year>) <volume>51</volume>:<page-range>103&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0920-9964(01)00246-8</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penttil&#xe4;</surname> <given-names>M</given-names>
</name>
<name>
<surname>J&#xe4;&#xe4;skel&#xe4;inen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hirvonen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Isohanni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Miettunen</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis</article-title>. <source>Br J Psychiatry</source>. (<year>2014</year>) <volume>205</volume>:<fpage>88</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1192/bjp.bp.113.127753</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salazar de Pablo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Aymerich</surname> <given-names>C</given-names>
</name>
<name>
<surname>Guinart</surname> <given-names>D</given-names>
</name>
<name>
<surname>Catalan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alameda</surname> <given-names>L</given-names>
</name>
<name>
<surname>Trotta</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>What is the duration of untreated psychosis worldwide? &#x2013; A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies</article-title>. <source>psychol Med</source>. (<year>2024</year>) <volume>54</volume>:<page-range>652&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/S0033291723003458</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGrath</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Saha</surname> <given-names>S</given-names>
</name>
<name>
<surname>Al-Hamzawi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alonso</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bromet</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Bruffaerts</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Psychotic experiences in the general population: a cross-national analysis based on 31 261 respondents from 18 countries</article-title>. <source>JAMA Psychiatry</source>. (<year>2015</year>) <volume>72</volume>:<fpage>697</fpage>&#x2013;<lpage>705</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.0575</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaya</surname> <given-names>ES</given-names>
</name>
<name>
<surname>W&#xfc;sten</surname> <given-names>C</given-names>
</name>
<name>
<surname>Alizadeh</surname> <given-names>BZ</given-names>
</name>
<name>
<surname>Van Amelsvoort</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bartels-Velthuis</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Van Beveren</surname> <given-names>NJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparing psychotic experiences in low-and-middle-income-countries and high-income-countries with a focus on measurement invariance</article-title>. <source>psychol Med</source>. (<year>2022</year>) <volume>52</volume>:<page-range>1509&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/S0033291720003323</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotlicka-Antczak</surname> <given-names>M</given-names>
</name>
<name>
<surname>Podg&#xf3;rski</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oliver</surname> <given-names>D</given-names>
</name>
<name>
<surname>Maric</surname> <given-names>NP</given-names>
</name>
<name>
<surname>Valmaggia</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fusar-Poli</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Worldwide implementation of clinical services for the prevention of psychosis: The IEPA early intervention in mental health survey</article-title>. <source>Early Interv Psychiatry</source>. (<year>2020</year>) <volume>14</volume>:<page-range>741&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/eip.12950</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freeman</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Investing for population mental health in low and middle income countries&#x2014;where and why</article-title>? <source>Int J Ment Health Syst</source>. (<year>2022</year>) <volume>16</volume>:<fpage>38</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13033-022-00547-6</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fekih-Romdhane</surname> <given-names>F</given-names>
</name>
<name>
<surname>Jahrami</surname> <given-names>H</given-names>
</name>
<name>
<surname>Stambouli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Alhuwailah</surname> <given-names>A</given-names>
</name>
<name>
<surname>Helmy</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shuwiekh</surname> <given-names>HAM</given-names>
</name>
<etal/>
</person-group>. <article-title>Cross-cultural comparison of mental illness stigma and help-seeking attitudes: a multinational population-based study from 16 Arab countries and 10,036 individuals</article-title>. <source>Soc Psychiatry Psychiatr Epidemiol</source>. (<year>2023</year>) <volume>58</volume>:<page-range>641&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00127-022-02403-x</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fekih-Romdhane</surname> <given-names>F</given-names>
</name>
<name>
<surname>Abassi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ghrissi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Loch</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Cherif</surname> <given-names>W</given-names>
</name>
<name>
<surname>Damak</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Suicide risk among individuals at Ultra-High Risk (UHR) of psychosis in a developing North African country: a 12-month naturalistic prospective cohort study from the TRIP project</article-title>. <source>Psychiatry Res</source>. (<year>2023</year>) <volume>327</volume>:<fpage>115409</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.psychres.2023.115409</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fekih-Romdhane</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ghrissi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Abassi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Loch</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Cherif</surname> <given-names>W</given-names>
</name>
<name>
<surname>Damak</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Impulsivity as a predictor of clinical and psychological outcomes in a naturalistic prospective cohort of subjects at ultra-high risk (UHR) for psychosis from Tunisia</article-title>. <source>Psychiatry Res</source>. (<year>2024</year>) <volume>340</volume>:<fpage>116090</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.psychres.2024.116090</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mamah</surname> <given-names>D</given-names>
</name>
<name>
<surname>Musau</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mutiso</surname> <given-names>VN</given-names>
</name>
<name>
<surname>Owoso</surname> <given-names>A</given-names>
</name>
<name>
<surname>Abdallah</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Cottler</surname> <given-names>LB</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterizing psychosis risk traits in Africa: A longitudinal study of Kenyan adolescents</article-title>. <source>Schizophr Res</source>. (<year>2016</year>) <volume>176</volume>:<page-range>340&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.schres.2016.08.004</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fekih-Romdhane</surname> <given-names>F</given-names>
</name>
<name>
<surname>Obeid</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hallit</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Psychotic experiences and symptoms in adolescents and young adults from different countries and cultural backgrounds</article-title>. <source>Front Media SA</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1275061</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpsyt.2023.1275061</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaspar</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Castillo</surname> <given-names>RI</given-names>
</name>
<name>
<surname>Maturana</surname> <given-names>A</given-names>
</name>
<name>
<surname>Villar</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Ulloa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research</article-title>. <source>Early Interv Psychiatry</source>. (<year>2019</year>) <volume>13</volume>:<page-range>328&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/eip.12766</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>